Stanford University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).
Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.
Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.
Top-decile sponsor footprint
Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,744 total, page 7 of 35
Effect of Preoperative Diet on Perioperative Gut Microbiome
NCT05027763
Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer
NCT05119296
Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies
NCT04925544
Maternal & Offspring Microbiome Study
NCT05123612
AN/BN Risk Factors Study
NCT05133037
Pre-post Evaluation of the Safety and Efficacy of Ibogaine-Magnesium Therapy in Veterans With Repeated Blast Exposure
NCT04313712
Neonatal Brain Oxygenation Study
NCT04439968
Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS
NCT04870255
Rapid Acting Transcranial Magnetic Stimulation
NCT04739969
Establishing a Dose-response Relationship With Accelerated Transcranial Magnetic Stimulation
NCT04243798
Transcranial Direct Current to Treat Epilepsy at Home
NCT04309812
Dual Intravitreal Implantation of NT-501 Encapsulated Cell Therapy for Glaucoma
NCT04577300
Integrating Support Persons Into Recovery
NCT04239235
CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma
NCT04727242
Neural Circuit Biomarkers of Transcranial Magnetic Stimulation Study
NCT04663841
SPRINT: Signature for Pain Recovery IN Teens
NCT04285112
Perioperative Optimization With Enhanced Recovery
NCT04504266
Opiate Suicide Study in Patients With Major Depression
NCT04116528
Utility of At-home Monitoring of Exercise Capacity by App-based 6-minute Walk Test
NCT03893500
Multiomic Signatures of Microbial Metabolites Following Prebiotic Fiber Supplementation
NCT03925597
CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies
NCT04088864
Supportive Care for Cognitively Impaired Patients and Families
NCT03881579
Listening to Mom 2: Neural, Clinical and Language Outcomes
NCT04193579
Correlate of Surface Electroencephalogram (EEG) With Implanted EEG Recordings (ECOG)
NCT03629743
Comparing Long-term Effectiveness of High Frequency and Burst Spinal Cord Stimulation
NCT03681262
AVATAR Anesthesia Alternative in Pediatric Radiotherapy: A Multi-Center Study
NCT03991156
A Center Based Study of Pivotal Response Treatment for Preschoolers With Autism
NCT03778827
Remote Monitoring of CGM Data in Pediatric Patients With Newly Diagnosed Type 1 Diabetes (T1D)
NCT03968055
Neural Mechanisms of Decision Making in Hoarding Disorder
NCT03487224
Precision Diets for Diabetes Prevention
NCT03919877
Meditation and Education That is Nurse Delivered for Symptom Management in Paroxysmal Atrial Fibrillation (PAF)
NCT03834844
Digital Symptom Tracking, Patient Engagement and Quality of Life in Advanced Cancer
NCT05112198
Study of CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults w/ Recurrent or Refractory B Cell Malignancies
NCT03241940
CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies
NCT03233854
Open/Aftercare Treatment for Participants Diagnosed With Obsessive Compulsive Disorder
NCT03511534
Understanding How Ketamine Brings About Rapid Improvement in OCD
NCT02624596
Study of NT-501 Encapsulated Cell Therapy for Glaucoma Neuroprotection and Vision Restoration
NCT02862938
Pilot Trial of Pregnenolone in Autism
NCT02627508
Stanford Center for Back Pain
NCT02503475
MyHeart Counts Cardiovascular Health Study
NCT03090321
High-Dose Brachytherapy in Treating Patients With Prostate Cancer
NCT02346253
Feasibility Neurocognitive Outcome After Transplant
NCT02300961
Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs
NCT00319657
Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer
NCT00185744
Acoustic Resonance Therapy for Treating Empty Nose Syndrome
NCT07215013
The Effects of Cannabis on Post Operative Recovery After Radical Cystectomy
NCT07577999
Simplifying Diet Tracking in a Digital Weight Loss Intervention
NCT07601061
Vagus Nerve Stimulation to Enhance Memory in Aging
NCT07214194
Clinical Trial Evaluating the Effects of Ganaxolone in Children With Autism
NCT07635862
Trial of Center-Based Early Start Denver Model vs. Pivotal Response Treatment in Children With Autism
NCT07522190
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 209 |
| Phase 3 | 51 |
| Phase 4 | 86 |
Therapeutic Areas
What is open in the Stanford University pipeline
264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).
Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).
Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.